ATTENTION: We are here for you during this COVID-19 pandemic and will continue to provide support.
Please click here for more COVID-19 information and resources.

Patient Information  |  Patient Videos  |  Clinician Guidelines & Resources

Arrhythmia Alliance News & Events

Discontinuation of Sale and Distribution of Coumadin (Warfarin Sodium) Tablets for oral use

 

Bristol-Myers Squibb announced that the sale and distribution of all strengths of Coumadin (Warfarin Sodium) tablets will be discontinued in the United States, Canada, Latin America, and Saudi Arabia, due to an unexpected manufacturing issue. 

This action is voluntary and is not the result of any quality, safety or efficacy issues regarding the product, but rather due to an unexpected manufacturing issue that cannot be resolved.

The discontinuation of this product in the U.S.A. happened on April 24th, 2020.

For more, click here 

Share

Send us your feedback

Patient Resources

To download our information resource and receive regular updates from Arrhythmia Alliance please enter your details below*:

No thanks

*Please note you can unsubscribe from our mailing list at any time

This link will take you to the site

Stay on this site